It was originally approved for the treatment of type 2 diabetes by the FDA in May 2022 under the brand name Mounjaro, and then, in response to the significant weight loss results during clinical trials, the FDA approved tirzepatide in November 2023 for chronic weight management under the name Zepbound
Urine drug screens (UDS) are immunoassay-based tests that detect specific classes of psychoactive substances and their metabolites
4,5,6 Will Mounjaro make my AF episodes more frequent
Oxytocin 6-11 Oxytocin causes G-protein coupled receptors to increase intracellular calcium which leads to uterine contraction
When combined with a GLP-1 receptor agonist like tirzepatide, which also influences appetite and metabolism, the interaction can shift how your body responds to treatment
stimulates GH release, appetite via hypothalamic ghrelin circuits, and modest cortisol/prolactin release through ACTH st